The morpholino-acetic acid analogue Sch 50911 is a selective GABAB receptor antagonist in rat neocortical slices
| dc.contributor.author | Ong, J. | |
| dc.contributor.author | Marino, V. | |
| dc.contributor.author | Parker, D. | |
| dc.contributor.author | Kerr, D. | |
| dc.contributor.author | Blythin, D. | |
| dc.date.issued | 1998 | |
| dc.description.abstract | The pharmacological properties of (+)-(S)-5,5-dimethylmorpholinyl-2-acetic acid (Sch 50911) were evaluated on GABA(B) receptors in rat neocortical slices. The GABA(B) receptor agonist, baclofen, produced a concentration-dependent depression of the frequency of spontaneous discharges in slices maintained in Mg2+-free Krebs medium with an EC50 of 6 microM, reversibly antagonised by Sch 50911 (5, 10 and 25 microM) with an apparent pA2 of 6.0 +/- 0.1. The (-) enantiomer Sch 50910 (500 microM) and the racemic des-methyl analogue Sch 48588 (500 microM) were inactive. In slices preloaded with [3H]GABA, Sch 50911 antagonised GABA(B) autoreceptors, increasing the electrically-stimulated 3H overflow in a concentration-dependent manner, with an IC50 of 3 microM. The maximal effect (148 +/- 10.5%) was found at 10 microM, but at 50 microM the response was reduced to 67 +/- 19%. In contrast, evoked release was unaffected by Sch 50910 (100 microM) whilst Sch 48588 at 100 microM increased the overflow by 51.3 +/- 11.6%. In summary, Sch 50911 is a relatively potent antagonist of considerable potential in studies of GABA(B) receptor function. | |
| dc.description.statementofresponsibility | Jennifer Ong, Victor Marino, David A.S. Parker, David I.B. Kerr, David J. Blythin | |
| dc.identifier.citation | European Journal of Pharmacology, 1998; 362(1):35-41 | |
| dc.identifier.doi | 10.1016/S0014-2999(98)00723-7 | |
| dc.identifier.issn | 0014-2999 | |
| dc.identifier.issn | 1879-0712 | |
| dc.identifier.orcid | Ong, J. [0000-0002-0958-460X] | |
| dc.identifier.uri | http://hdl.handle.net/2440/5991 | |
| dc.language.iso | en | |
| dc.publisher | ELSEVIER SCIENCE BV | |
| dc.relation.grant | ARC | |
| dc.source.uri | https://doi.org/10.1016/s0014-2999(98)00723-7 | |
| dc.subject | Neocortex | |
| dc.subject | Animals | |
| dc.subject | Rats | |
| dc.subject | Rats, Sprague-Dawley | |
| dc.subject | Baclofen | |
| dc.subject | Morpholines | |
| dc.subject | GABA Antagonists | |
| dc.subject | Dose-Response Relationship, Drug | |
| dc.subject | Male | |
| dc.subject | GABA-B Receptor Antagonists | |
| dc.subject | In Vitro Techniques | |
| dc.title | The morpholino-acetic acid analogue Sch 50911 is a selective GABAB receptor antagonist in rat neocortical slices | |
| dc.type | Journal article | |
| pubs.publication-status | Published |